Opentrons Labworks announced October 29 that it raised $40 million in Series E financing to expand its laboratory robotics, software and data infrastructure.
Healthcare investor Avego led the round, with participation from BroadOak Capital Partners. The company named SoftBank Vision Fund and Khosla Ventures among existing investors.
Opentrons says the funding will support AI-driven experimental execution, additional automation capabilities and expansion into new markets and regions. It also plans faster protocol development and closer integration with other laboratory systems.
Its Flex platform combines robots with software intended to connect experiment design, physical execution and subsequent analysis. The distinction matters because an AI-generated hypothesis still requires testing through physical experiments.
The company reported deploying more than 11,000 robots in over 80 countries. Those installation figures are company-reported rather than an independently audited market measure.
The financing announcement describes planned investment in research tools. It does not establish that an automated experiment will produce a successful scientific result or that the platform can independently validate every hypothesis.
Sources: Opentrons — October 29 Business Wire Financing Release, Reprinted by MedicaEx: https://medicaex.com/businesswire/opentrons-announces-40m-series-e-round-to-standardize-ai-driven-science-on-its-robots/